数据链接：
官方服务：
资源简介：
Examples of prior EWAS performed in NAFLD and NASH.
应用场景：
创建时间：
2023-01-19
相关数据集
Super Enhancer Regulation of Cytokine-Induced Chemokine Production in Alcoholic Hepatitis [ChIP-Seq]
We performed histone modification ChIP-Seq in human liver explants and showed upregulation of multiple CXCL chemokines in AH. ChIP-Seq, chromosome conformation capture assays, and in silico analysis o
NIAID Data Ecosystem70
DNA IP for 5hmC modified CpGs in the liver of control and HFD fed mouse liver.. DNA IP for 5hmC modified CpGs in the liver of control and HFD fed mouse liver.
We carry out 5-hydroxymethylation DNA immunoprecipitation (hmeDIP) prior to sequencing Ion Proton P1 to report on the genome-wide 5hmC patterns of hepatic in murine hepatic steatosis. Overall design:
NIAID Data Ecosystem30
Alterations in the hepatocyte epigenetic landscape in steatosis
Fatty liver disease or the buildup of fat in the liver, has been reported to affect the global population. This comes with an increased risk for the development of fibrosis, cirrhosis, and hepatocellu
NIAID Data Ecosystem10
Methylation profiles in non-alcoholic fatty liver disease
Background & Aims: Cirrhosis and liver cancer are potential outcomes of advanced nonalcoholic fatty liver disease (NAFLD). It is not clear what factors determine whether patients will develop advanced
NIAID Data Ecosystem60
Human liver biopsy of different phases from control to NASH
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disorder in industrialized countries. Liver samples from morbidly obese patients (N=45) with all stages of NAFLD and controls
NIAID Data Ecosystem20
